APOE-ε4 is not associated with cognitive impairment in relapsing - Remitting multiple sclerosis

Multiple Sclerosis

Volumn 15, Issue 12, 2009, Pages 1489-1494

  Portaccio, Emilio ^a   Goretti, Benedetta ^a   Zipoli, Valentina ^a   Nacmias, Benedetta ^a   Stromillo, Maria Laura ^b   Bartolozzi, Maria Letizia ^c   Siracusa, Gianfranco ^a   Guidi, Leonello ^c   Federico, Antonio ^b   Sorbi, Sandro ^a   De Stefano, Nicola ^b   Pia Amato, Maria ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c Hospital of Empoli   (Italy)

Author keywords

Apolipoprotein E; Cognitive impairment; Magnetic resonance; Multiple sclerosis

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON4; UNCLASSIFIED DRUG; APOLIPOPROTEIN E4;

ADULT; AGE DISTRIBUTION; ARTICLE; BRAIN ATROPHY; BRAIN CORTEX; BRAIN SIZE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOSITY; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; POPULATION RESEARCH; TASK PERFORMANCE; VERBAL MEMORY; ATTENTION; BRAIN; COGNITION; DISABILITY; GENETIC PREDISPOSITION; GENETICS; HOSPITALIZATION; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PHENOTYPE; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL;

ADULT; APOLIPOPROTEIN E4; ATTENTION; BRAIN; COGNITION; COGNITION DISORDERS; DISABILITY EVALUATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ITALY; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROPSYCHOLOGICAL TESTS; PHENOTYPE; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 72749094049     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509348512     Document Type: Article

References (26)

1. Amato MP, Zipoli V., Portaccio E. Cognitive changes in multiple sclerosis. Expert Rev Neurother 2008 ; 8: 1585-1596.
2. Amato MP, Ponziani G., Siracusa G., Sorbi *S. Cognitive dysfunction in early-onset multiple sclerosis: A reappraisal after 10 years. Arch Neurol 2001 ; 58: 1602-1606.
3. Siest G., Pillot T., Regis-Bailly A., et al. Apolipoprotein E: An important gene and protein to follow in laboratory medicine. Clin Chem 1995 ; 41: 1068-1086.
4. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimers disease. Trends Neurosci 1994 ; 17: 525-530.
5. Nathan BP, Bellosta S., Sanan DA, Weisgraber KH, Mahley RW, Pitas RE Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 1994 ; 264 (5160). 850-852.
6. Holtzman DM, Fagan AM Potential role of apoE in structural plasticity in the nervous system; implications for disorders of the central nervous system. Trends Cardiovasc Med 1998 ; 8: 250-255.
7. Mahley RW, Rall SC, Jr. Apolipoprotein E: Far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000 ; 1: 507-537.
8. Strittmatter WJ, Saunders AM, Schmechel D., et al. Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 1993 ; 90: 1977-1981.
9. Bondi MW, Salmon DP, Monsch AU, et al. Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adults. Neurology 1995 ; 45: 2203-2206.
10. Crawford FC, Vanderploeg RD, Freeman MJ, et al. APOE genotype influences acquisition and recall following traumatic brain injury. Neurology 2002 ; 58: 1115-1118.
11. Gambardella A., Aguglia U., Chifari R., et al. ApoE epsilon4 allele and disease duration affect verbal learning in mild temporal lobe epilepsy. Epilepsia 2005 ; 46: 110-117.
12. Burwick RM, Ramsay PP, Haines JL, et al. APOE epsilon variation in multiple sclerosis susceptibility and disease severity: Some answers. Neurology 2006 ; 66: 1373-1383.
13. Koutsis G., Panas M., Giogkaraki E., et al. APOE epsilon4 is associated with impaired verbal learning in patients with MS. Neurology 2007 ; 68: 546-549.
14. Shi J., Zhao CB, Vollmer TL, Tyry TM, Kuniyoshi SM APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis. Neurology 2008 ; 70: 185-190.
15. Sadovnick AD, Jacobs DH MS and cognition and APOE: The ongoing conundrum about biomarkers. Neurology 2008 ; 70: 164-165.
16. Polman CH, Reingold SC, Edan G., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria. Ann Neurol 2005 ; 58: 840-846.
17. Sorbi S., Nacmias B., Forleo P., et al. ApoE allele frequencies in Italian sporadic and familial Alzheimers disease. Neurosci Lett 1994 ; 177: 100-102.
18. Kurtzke JF Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS). Neurology 1983 ; 33: 1444-1452.
19. Rao SM the Cognitive Function Study Group of the National Multiple Sclerosis Society. A manual for the Brief Repeatable Battery of Neuropsychological Tests in Multiple Sclerosis. Milwaukee, WI: Medical College of Wisconsin, 1990.
20. Barbarotto R., Laiacona M., Frosio R., Vecchio M., Farinato A., Capitani E. A normative study on visual reaction times and two Stroop colour-word tests. Ital J Neurol Sci 1998 ; 19: 161-170.
21. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979 ; 134: 382-389.
22. Amato MP, Portaccio E., Goretti B., et al. The Raos Brief Repeatable Battery and Stroop Test: Normative values with age, education and gender corrections in an Italian population. Mult Scler 2006 ; 12: 787-793.
23. Camp SJ, Stevenson VL, Thompson AJ, et al. Cognitive function in primary progressive and transitional progressive multiple sclerosis: A controlled study with MRI correlates. Brain 1999 ; 122: 1341-1348.
24. Smith SM, Zhang Y., Jenkinson M., et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002 ; 17: 479-489.
25. De Stefano N., Matthews PM, Filippi M., et al. Evidence of early cortical atrophy in MS: Relevance to white matter changes and disability. Neurology 2003 ; 60: 1157-1162.
26. Sicotte NL, Kern KC, Giesser BS, et al. Regional hippocampal atrophy in multiple sclerosis. Brain 2008 ; 131: 1134-1141.